Skip to content
The Nexus
HEALTHJun 23 · 05:00 UTCTHE GUARDIAN WORLDAndrew Gregory Health editor

Drug that delays onset of type 1 diabetes approved in England and Wales

The drug teplizumab, which delays the onset of type 1 diabetes for up to three years, has been approved for NHS use in England and Wales. It marks the first treatment of its kind and is described as a major breakthrough in diabetes care.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
teplizumabtopicNHSorganizationEnglandplaceWalesplacetype 1 diabetestopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting